Financing deal worth €15.0 million signed to support clinical development programme for masitinib Masitinib developed as a credible candidate for treating…
(PRESS RELEASE) MUNICH, 09-Jan-2019 — /EuropaWire/ — Defects in the geneTREM2 are linked to increased risk of Alzheimer’s disease. The gene…